April 19, 2018 / 5:33 AM / a month ago

BRIEF-4SC AG: Phase II Study Of Resminostat In Biliary Tract Cancer In Japan Initiated

April 19 (Reuters) - 4Sc AG:

* DGAP-NEWS: 4SC AG: PHASE II STUDY OF 4SC’S RESMINOSTAT IN BILIARY TRACT CANCER IN JAPAN IS INITIATED

* FINAL RESULTS ARE EXPECTED TO BE AVAILABLE BY MID-2020 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below